PPARγ regulates both the terminal differentiation and metabolism in mature adipocytes42 and its activation renders leukemic stem cells, previously resistant to treatment, susceptible to targeted therapy in CML.43 The gene discussed is PPARG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.